Manabu Ohyama
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 155 publications
Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience.
Journal: Immunological medicine
Published: March 27, 2026
Risk and Impact of Cytomegalovirus Infection in Bullous Pemphigoid Patients Treated With Immunosuppressive Agents.
Journal: The Journal of dermatology
Published: February 28, 2026
How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach.
Journal: Dermatology and therapy
Published: January 27, 2026
Collapse of Immune Privilege in the Sweat Gland in a Sjögren Disease Patient With Generalized Anhidrosis.
Journal: The Journal of dermatology
Published: December 22, 2025
Correction: Generation of Human Melanocytes from Induced Pluripotent Stem Cells.
Journal: PloS one
Published: November 24, 2025
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicentre, randomized, double-blinded, placebo-controlled trial.
Journal: The British journal of dermatology
Published: September 24, 2025
Morphometric prediction of mesenchymal stromal cell-like immunosuppressive capacity of human hair follicle dermal sheath cup cells: an implication for regenerative medicine in hair loss diseases.
Journal: Stem cell research & therapy
Published: July 31, 2025
Nemolizumab Treatment for Severe Atopic Dermatitis Led to the Simultaneous Improvement of Coexisting Refractory Alopecia Areata: A Case Report.
Journal: The Journal of dermatology
Published: July 25, 2025
Trichotemnomania: A Case Report With Insights Into the Techniques Enabling Effective Diagnosis.
Journal: The Journal of dermatology
Published: July 24, 2025
Japanese Dermatological Association's Clinical Practice Guidelines for Alopecia Areata 2024: A Complete English Translated Version.
Journal: The Journal of dermatology
Published: June 26, 2025
An acyclic nucleic acid-modified siRNA targeting CAG expansions for polyglutamine disease treatment.
An acyclic nucleic acid-modified siRNA targeting CAG expansions for polyglutamine disease treatment.
Journal: Molecular therapy. Nucleic acids
Published: June 26, 2025
Last Updated: 09/26/2026